Diagnosis of Systemic Rheumatic Disease Using the Connective Tissue Disease Screen

Area of Science:

• Rheumatology
• Immunology
• Clinical Diagnostics

Background:

• Connective tissue diseases (CTDs) are complex autoimmune conditions with varied presentations.
• Accurate diagnosis of CTDs is challenging due to diverse clinical features and autoantibody profiles.
• Automated screening assays for CTDs aim to improve diagnostic efficiency.

Purpose of the Study:

• To systematically review and meta-analyze the diagnostic performance of automated CTD screening assays.
• To evaluate the sensitivity and specificity of these assays in identifying systemic rheumatic diseases.

Main Methods:

• Systematic review and meta-analysis of eleven studies.
• Inclusion of cohort and case-control studies.
• Analysis of data from 2384 CTD-positive patients, 8972 controls, and 679 healthy donors.

Main Results:

• Pooled sensitivity and specificity for Elia® CTD-screen were 79.36% and 90.79%, respectively.
• Pooled sensitivity and specificity for QuantaFlash® CTD-screen were 87.23% and 83.56%, respectively.
• Assays showed excellent specificity in distinguishing CTD patients from healthy controls but varied sensitivity across specific CTDs.

Conclusions:

• Automated CTD screens are valuable tools but should not replace clinical evaluation.
• Positive predictive value limitations necessitate careful interpretation, especially in low-prevalence settings.
• Integrating CTD screens with clinical judgment can enhance diagnostic efficiency and reduce costs.